Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
xconomy.com » Xconomy - Nov 5, 2008
Biotech, Surgical Bleeding, Life Sciences Luke Timmerman wrote: (Update: This story has been updated to add material from ZymoGenetics’ conference call with analysts, starting with the fourth paragraph.) ZymoGenetics …
Also tagged: seattle, biotech, life sciences, zymogenetics, surgical bleeding, national blog main, seattle blog main, deerfield management
xconomy.com » Xconomy Life Sciences Feed - Nov 4, 2008
Biotech, Surgical Bleeding, Life Sciences Luke Timmerman wrote: ZymoGenetics still hasn’t found a groove with its recombinant thrombin drug (Recothrom) for surgical bleeding. The Seattle biotech company said today it …
Also tagged: seattle, biotech, life sciences, zymogenetics, surgical bleeding, national blog main, seattle blog main, deerfield management
 |
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patientsxconomy.com » Xconomy Seattle - Oct 23, 2008 Biotech, cancer, Kidney Luke Timmerman wrote: ZymoGenetics has some minor good news coming out today. The Seattle biotech company said that a study showed its genetically-engineered protein drug, IL-21, was able to … Also tagged: cancer, seattle, biotech, pfizer, bayer, kidney, american cancer society, sutent, nexavar, hepatitis c, life sciences, sorafenib, zymogenetics, onyx pharmaceuticals, national blog main, seattle blog main, sunitinib, il 21, american association for the study of liver disease, eortc nci aacr, recombinant thrombin, nicole onetto |
|
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patientsxconomy.com » Xconomy Life Sciences Feed - Oct 22, 2008 Biotech, cancer, Kidney Luke Timmerman wrote: ZymoGenetics has some minor good news coming out today. The Seattle biotech company said that a study showed its genetically-engineered protein drug, IL-21, was able to … Also tagged: cancer, seattle, biotech, pfizer, bayer, kidney, american cancer society, sutent, nexavar, hepatitis c, life sciences, sorafenib, zymogenetics, onyx pharmaceuticals, national blog main, seattle blog main, sunitinib, il 21, american association for the study of liver disease, eortc nci aacr, recombinant thrombin, nicole onetto |
xconomy.com » Xconomy Life Sciences Feed - Sep 9, 2008
Biotech, cancer, Seattle Genetics Luke Timmerman wrote: The people at Seattle Genetics think they have a blockbuster-drug-in-the-making for Hodgkin’s disease. Tom Reynolds is the guy whose job it is to prove it to the …
Also tagged: cancer, seattle, biotech, fda, novartis, rituxan, gleevec, genentech, stanford university, avastin, american society of clinical oncology, zymogenetics, hodgkin s disease, tom reynolds, targeted genetics, seattle genetics, san juan islands, national blog main, seattle blog main, sgn 35, sgn 15, clay siegall, sgn 30, sgn 10
xconomy.com » Xconomy - Sep 8, 2008
Biotech, cancer, Seattle Genetics Luke Timmerman wrote: The people at Seattle Genetics think they have a blockbuster-drug-in-the-making for Hodgkin’s disease. Tom Reynolds is the guy whose job it is to prove it to the …
Also tagged: cancer, seattle, biotech, fda, novartis, rituxan, gleevec, genentech, stanford university, avastin, american society of clinical oncology, zymogenetics, hodgkin s disease, tom reynolds, targeted genetics, seattle genetics, san juan islands, national blog main, seattle blog main, sgn 35, sgn 15, clay siegall, sgn 30, sgn 10
xconomy.com » Xconomy Life Sciences Feed - Sep 2, 2008
Biotech, Surgical Bleeding, ZymoGenetics Luke Timmerman wrote: ZymoGenetics is going to try to crack the European pharmaceutical market. The Seattle biotech company (NASDAQ: ZGEN) said today that its partner, Bayer …
Also tagged: european union, seattle, biotech, bayer, king pharmaceuticals, zymogenetics, surgical bleeding, national blog main, seattle blog main, thrombin jmi, susan specht
xconomy.com » Xconomy Seattle - Sep 2, 2008
Biotech, Surgical Bleeding, ZymoGenetics Luke Timmerman wrote: ZymoGenetics is going to try to crack the European pharmaceutical market. The Seattle biotech company (NASDAQ: ZGEN) said today that its partner, Bayer …
Also tagged: european union, seattle, biotech, bayer, king pharmaceuticals, zymogenetics, surgical bleeding, national blog main, seattle blog main, thrombin jmi, susan specht
xconomy.com » Xconomy Seattle - Aug 30, 2008
Biotech, Life Sciences, ZymoGenetics Luke Timmerman wrote: ZymoGenetics, the Seattle biotech company that markets Recothrom for surgical bleeding, said today in a regulatory filing that it has sold a parcel of lake …
Also tagged: seattle, biotech, life sciences, zymogenetics, seattle briefs
xconomy.com » Xconomy - Aug 29, 2008
Biotech, Life Sciences, ZymoGenetics Luke Timmerman wrote: ZymoGenetics, the Seattle biotech company that markets Recothrom for surgical bleeding, said today in a regulatory filing that it has sold a parcel of lake …
Also tagged: seattle, biotech, life sciences, zymogenetics, seattle briefs